These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy. Spencer DA; Auffinger BM; Murphy JP; Muroski ME; Qiao J; Gorind Y; Lesniak MS Curr Cancer Drug Targets; 2017; 17(3):236-254. PubMed ID: 27993114 [TBL] [Abstract][Full Text] [Related]
23. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications. Papavassiliou KA; Papavassiliou AG Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431 [TBL] [Abstract][Full Text] [Related]
24. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients. Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757 [TBL] [Abstract][Full Text] [Related]
25. Current Challenges and Opportunities in Treating Glioblastoma. Shergalis A; Bankhead A; Luesakul U; Muangsin N; Neamati N Pharmacol Rev; 2018 Jul; 70(3):412-445. PubMed ID: 29669750 [TBL] [Abstract][Full Text] [Related]
26. Novel approaches to targeting gliomas at the leading/cutting edge. Schupper AJ; Hadjipanayis CG J Neurosurg; 2023 Sep; 139(3):760-768. PubMed ID: 36840741 [TBL] [Abstract][Full Text] [Related]
27. Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Alves ALV; Gomes INF; Carloni AC; Rosa MN; da Silva LS; Evangelista AF; Reis RM; Silva VAO Stem Cell Res Ther; 2021 Mar; 12(1):206. PubMed ID: 33762015 [TBL] [Abstract][Full Text] [Related]
37. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma. Tang L; Zhang M; Liu C Front Immunol; 2022; 13():882257. PubMed ID: 35651605 [TBL] [Abstract][Full Text] [Related]
38. Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. Kardani K; Sanchez Gil J; Rabkin SD Front Cell Infect Microbiol; 2023; 13():1206111. PubMed ID: 37325516 [TBL] [Abstract][Full Text] [Related]
39. Comparison of glioblastoma (GBM) molecular classification methods. Lee E; Yong RL; Paddison P; Zhu J Semin Cancer Biol; 2018 Dec; 53():201-211. PubMed ID: 30031763 [TBL] [Abstract][Full Text] [Related]
40. Neuronal and tumourigenic boundaries of glioblastoma plasticity. De Silva MI; Stringer BW; Bardy C Trends Cancer; 2023 Mar; 9(3):223-236. PubMed ID: 36460606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]